Development of a subunit vaccine against the cholangiocarcinoma causing Opisthorchis viverrini : a computational approachImmunology Original Research Published on 2024-07-102024-09-05 Journal: Frontiers in immunology [Category] update2024, [키워드] Cholangiocarcinoma epitope Opisthorchis viverrini parasite; immunoinformatics-based vaccine designing Vaccine [DOI] 10.3389/fimmu.2024.1281544 PMC 바로가기 [Article Type] Immunology Original Research
A systematic review of the effects of hepatitis B and C virus on the progression of liver fluke infection to liver cancerReview Published on 2024-03-152024-09-05 Journal: Tropical Diseases, Travel Medicine and Vaccines [Category] update2024, [키워드] Cholangiocarcinoma Clonorchis sinensis Hepatitis Hepatocellular carcinoma Liver cancer Liver flukes Opisthorchis viverrini [DOI] 10.1186/s40794-023-00215-8 PMC 바로가기 [Article Type] Review
Current State of Knowledge on Blood and Tissue-Based Biomarkers for Opisthorchis viverrini -induced Cholangiocarcinoma: A Review of Prognostic, Predictive, and Diagnostic MarkersReview Article Published on 2024-01-012024-09-05 Journal: Asian Pacific Journal of Cancer Prevention : APJCP [Category] update2024, [키워드] biological markers Cholangiocarcinoma opisthorchiasis Opisthorchis viverrine Prognosis [DOI] 10.31557/APJCP.2024.25.1.25 PMC 바로가기 [Article Type] Review Article
SARS-CoV-2 vaccination in patients with GI and hepatobiliary carcinoma: a call for booster vaccinationComment Published on 2023-06-012023-07-10 Journal: Gut [Category] COVID19(2023년), [키워드] Cholangiocarcinoma COVID-19 hepatobiliary cancer Hepatocellular carcinoma immune response [DOI] 10.1136/gutjnl-2022-328169 [Article Type] Comment
Disparities in care and outcomes for primary liver cancer in England during 2008–2018: a cohort study of 8.52 million primary care population using the QResearch databasearticle Published on 2023-05-112024-09-05 Journal: EClinicalMedicine [Category] update2024, [키워드] Cholangiocarcinoma Disparities Epidemiology hepatocellular carcinoma (HCC) Liver cancer [DOI] 10.1016/j.eclinm.2023.101969 PMC 바로가기 [Article Type] article
Isolated anti-HBc is an independent risk factor for tumor recurrence in intrahepatic cholangiocarcinoma after curative resectionArticle Published on 2022-10-012023-06-09 Journal: Hepatobiliary & pancreatic diseases international : HBPD INT [Category] B형 간염, [키워드] Cholangiocarcinoma Hepatitis B virus Isolated antibody to hepatitis B core antigen Occult hepatitis B infection [DOI] 10.1016/j.hbpd.2022.07.010
15-Year progression to liver cancer in the lack of treatment for lysosomal acid lipase deficiency: A case reportArticle Published on 2022-09-022022-11-16 Journal: Medicine [Category] 변종, [키워드] acid lipase deficiency age cardiovascular complications Case report change characterized Cholangiocarcinoma cholesteryl ester cirrhosis coronavirus disease COVID-19 Deterioration diagnosed Diagnosis enzyme fibrosis Follow-up genetic disorder HCC Hepatocellular carcinoma hepatocyte higher risk IMPROVE individual Kupffer cells Laboratory lack LIPA liver Liver cancer Liver damage Liver function lysosomal male malignancy Mutation Neoplasms nodule pandemic Patient progression reduce reported Sebelipase alfa steatosis therapy tissues treat treated Treatment Triglyceride variant worsening [DOI] 10.1097/MD.0000000000030315 PMC 바로가기
Precision oncology for intrahepatic cholangiocarcinoma in clinical practice Research Published on 2022-08-192022-10-05 Journal: British Journal of Cancer [Category] 변종, 유전자 메커니즘, 임상, [키워드] alteration applied approach ARID1A ATM BAP1 BRAF Care CDKN2A CDKN2B Chemotherapy Chemotherapy treatment Cholangiocarcinoma Clinical practice Clinical treatment Combination Deterioration DNA and RNA FGFR2 FGFR3 formalin-fixed paraffin-embedded gene fusion IDH1 IDH2 intrahepatic involved loci molecular NRG1 oncology Patient patients performance status PIK3CA poor prognosis Probability progression receiving Result Sequencing significantly higher SMARCA4 survival target targeted therapy therapy tissue TP53 translated Treatment was performed [DOI] 10.1038/s41416-022-01932-1 [Article Type] Research
WWP1 upregulation predicts poor prognosis and promotes tumor progression by regulating ubiquitination of NDFIP1 in intrahepatic cholangiocarcinomaArticle Published on 2022-03-092022-10-04 Journal: Cell Death Discovery [Category] 바이오마커, [키워드] Bile duct cancer Biological functions CCK-8 Cell Cholangiocarcinoma chromatin immunoprecipitation Clinical prognosis correlated detect Effect expressed expression expression pattern facilitate Hepatocellular carcinoma ICC IHC immunofluorescence immunohistochemistry intrahepatic investigated Mechanisms of disease Metastasis molecular mechanism MYC NDFIP1 Oncogenes overexpression Patient performed poor prognosis potential mechanisms potential therapeutic target predict progression proliferation promote promoter region Protein protein level reduce reported rescued reveal target tissue tissues Transwell tumor progression Ubiquitylation upregulated upregulation were used WWP1 [DOI] 10.1038/s41420-022-00882-0 PMC 바로가기 [Article Type] Article
Update on the association of hepatitis B with intrahepatic cholangiocarcinoma: Is there new evidence?Review Published on 2021-07-212023-06-09 Journal: World journal of gastroenterology [Category] B형 간염, [키워드] Chemotherapy Cholangiocarcinoma hepatitis B Hepatocellular carcinoma intrahepatic Resection [DOI] 10.3748/wjg.v27.i27.4252 PMC 바로가기 [Article Type] Review